Current Status and Prospects of the Single-Cell Sequencing Technologies for Revealing the Pathogenesis of Pregnancy-Associated Disorders

Genes (Basel). 2023 Mar 20;14(3):756. doi: 10.3390/genes14030756.

Abstract

Single-cell RNA sequencing (scRNA-seq) is a method that focuses on the analysis of gene expression profile in individual cells. This method has been successfully applied to answer the challenging questions of the pathogenesis of multifactorial diseases and open up new possibilities in the prognosis and prevention of reproductive diseases. In this article, we have reviewed the application of scRNA-seq to the analysis of the various cell types and their gene expression changes in normal pregnancy and pregnancy complications. The main principle, advantages, and limitations of single-cell technologies and data analysis methods are described. We discuss the possibilities of using the scRNA-seq method for solving the fundamental and applied tasks related to various pregnancy-associated disorders. Finally, we provide an overview of the scRNA-seq findings for the common pregnancy-associated conditions, such as hyperglycemia in pregnancy, recurrent pregnancy loss, preterm labor, polycystic ovary syndrome, and pre-eclampsia.

Keywords: bioinformatics; hyperglycemia in pregnancy; polycystic ovary syndrome; pre-eclampsia; pregnancy-associated disorders; preterm labor; recurrent pregnancy loss; reproductive diseases; single-cell RNA sequencing.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Gene Expression Profiling* / methods
  • Humans
  • Infant, Newborn
  • Pre-Eclampsia*
  • Pregnancy
  • Sequence Analysis, RNA / methods
  • Single-Cell Analysis / methods
  • Transcriptome

Grants and funding

This research was supported by the Ministry of Science and Higher Education of the Russian Federation (project “Multicenter research bioresource collection” “Human Reproductive Health” contract No. 075-15-2021-1058 from 28 September 2021).